Telix Pharmaceuticals Limited American Depositary Shares Earnings Dividend

Telix Pharmaceuticals Limited American Depositary Shares’s price-to-earnings ratio after this Q2 2026 earnings stands at 117.8.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 0 - a 100% jump from last quarter’s estimates.

Telix Pharmaceuticals Limited American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 0.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Telix Pharmaceuticals Limited American Depositary Shares’s return on assets (ROA) stands at 0.03.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Telix Pharmaceuticals Limited American Depositary Shares’s return on equity (ROE) stands at 0.07.